Role of sgcR3 in positive regulation of enediyne antibiotic C-1027 production of Streptomyces globisporus C-1027 by Wang, Lifei et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
BMC Microbiology
Open Access Research article
Role of sgcR3 in positive regulation of enediyne antibiotic C-1027 
production of Streptomyces globisporus C-1027
Lifei Wang, Yunfeng Hu, Yanjuan Zhang, Songmei Wang, Zhihui Cui, Yi Bao, 
Wei Jiang and Bin Hong*
Address: Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, PR China
Email: Lifei Wang - lifeiwang2002@hotmail.com; Yunfeng Hu - yunfenghu29@yahoo.com.cn; Yanjuan Zhang - zhangyjuan@hotmail.com; 
Songmei Wang - wsm840208@hotmail.com; Zhihui Cui - cuizhihui3699@hotmail.com; Yi Bao - baoyi.cams@gmail.com; 
Wei Jiang - jiangv@163bj.com; Bin Hong* - binhong69@hotmail.com
* Corresponding author    
Abstract
Background: C-1027, produced by Streptomyces globisporus C-1027, is one of the most potent
antitumoral agents. The biosynthetic gene cluster of C-1027, previously cloned and sequenced,
contains at least three putative regulatory genes, i.e. sgcR1, sgcR2 and sgcR3. The predicted gene
products of these genes share sequence similarities to StrR, regulators of AraC/XylS family and
TylR. The purpose of this study was to investigate the role of sgcR3 in C-1027 biosynthesis.
Results: Overexpression of sgcR3 in S. globisporus C-1027 resulted in a 30–40% increase in C-1027
production. Consistent with this, disruption of sgcR3  abolished C-1027 production.
Complementation of the sgcR3-disrupted strain R3KO with intact sgcR3 gene could restore C-1027
production. The results from real time RT-PCR analysis in R3KO mutant and wild type strain
indicated that not only transcripts of biosynthetic structural genes such as sgcA1 and sgcC4, but also
putative regulatory genes, sgcR1 and sgcR2, were significantly decreased in R3KO mutant. The
cross-complementation studies showed that sgcR1R2  could functionally complement sgcR3
disruption in trans. Purified N-terminal His10-tagged SgcR3 showed specific DNA-binding activity to
the promoter region of sgcR1R2.
Conclusion: The role of SgcR3 has been proved to be a positive regulator of C-1027 biosynthesis
in S. globisporus C-1027. SgcR3 occupies a higher level than SgcR1 and SgcR2 in the regulatory
hierarchy that controls C-1027 production and activates the transcription of sgcR1 and sgcR2 by
binding directly to the promoter region of sgcR1R2.
Background
C-1027, also called lidamycin, is a chromoprotein antitu-
mor antibiotic produced by Streptomyces globisporus C-
1027 [1]. As a member of the enediyne family character-
ized by two acetylenic groups conjugated to a double
bond within a 9- or 10-membered ring, C-1027 is 1,000
times more potent than adriamycin, one of the most effec-
tive chemotherapeutic agents [2]. C-1027 is a complex
consisting of a 1:1 non-covalently associated mixture of
an apoprotein and a 9-membered enediyne chromo-
phore. The chromophore of the enediyne family can
undergo a rearrangement to form a transient benzenoid
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diradical species that can abstract hydrogen atoms from
DNA to initiate a cascade leading to DNA breaks, ulti-
mately leading to cell death [3,4]. This novel mode of
action has attracted great interest in developing these
compounds into therapeutic agents for cancer. A CD33
monoclonal antibody (mAB)-calicheamicin (CAL) conju-
gate (Mylotarg) and neocarzinostatin (NCS) conjugated
with poly (styrene-co-maleic acid) (SMANCS) were
approved in the USA [5] and in Japan [6], respectively.
Recently, C-1027 has entered phase II clinical trial in
China [7]. Appreciation of the immense pharmacological
potential of enediynes has led to a demand for the eco-
nomical production of C-1027 and its analogues at an
industrial scale.
Control of secondary metabolite production in strepto-
mycetes and related actinomycetes is a complex process
involving multiple levels of regulation in response to
environmental factors [For review, see [8,9]]. In most
cases that have been studied in detail, the final checkpoint
in production of a secondary metabolite is a pathway-spe-
cific transcriptional regulatory gene situated in the biosyn-
thetic cluster. Remarkable progress has been made in
dissecting the functions of the pathway-specific regula-
tors. For example, ActII-ORF4 regulates transcription from
the actinorhodin biosynthetic genes of S. coelicolor [10,11]
and StrR controls the streptomycin biosynthetic cluster of
S. griseus [12,13]. Recently, along with the tremendous
increase in sequence information for secondary metabolic
gene clusters, more and more clusters with multiple clus-
ter-situated regulators were reported (e.g., [14-17]). The
best studied multiple pathway-specific regulatory cascade
involves remarkably five regulatory genes in tylosin bio-
synthetic gene cluster of S. fradiae, and a model for their
regulation has been proposed [14,18-23]. Deciphering
the complexity of these pathway-specific regulatory net-
works is of great interest not only for better understanding
of the antibiotic regulatory mechanism, but also for pro-
viding new strategy for targeted genetic engineering of
antibiotic producing strains.
C-1027 nonpeptidic chromophore is a structure of an
enediyne core, a deoxy aminosugar, a β-amino acid and a
benzoxazolinate (Fig. 1) [7]. The biosynthetic gene cluster
for C-1027, which is the first cloned enediyne gene clus-
ter, contains a total of 56 open reading frames (ORFs) in
a region of 75 kbp [24,25]. Bioinformatic analysis and
biochemical studies revealed a distinct iterative type I
enediyne polyketide synthase (SgcE) and provided a con-
vergent biosynthetic strategy for C-1027 from four biosyn-
thetic building blocks [25]. Further cloning and
characterization of biosynthetic gene clusters for four
other enediynes (CAL [26], NCS [27], maduropeptin
(MDP) [28] and dynemicin [29]) confirmed the unifying
paradigm for enediyne biogenesis. In accordance with the
complexity of the biosynthetic process, there are no fewer
than three ORFs annotated as transcriptional regulators in
each known enediyne antibiotic biosynthetic cluster. At
least three putative regulatory genes (sgcR1,  sgcR2  and
sgcR3) associated with the C-1027 biosynthetic gene clus-
ter of S. globisporus C-1027 were annotated in the earlier
work by sequence analysis [25]. Furthermore, the biosyn-
thetic gene clusters for two 9-membered enediynes pro-
duced by streptomycetes (C-1027 and NCS) show high
similarity in the organization of genes around these regu-
latory genes (Fig. 2A). Despite chromophore structural
uniqueness, all homologues of three genes are located
adjacent to the genes of enediyne PKSs (sgcE and ncsE)
and the tailoring enzymes (E1 to E11), which are respon-
sible for the biosynthesis of enediyne core. However,
almost no cognitional knowledge was acquired about the
transcriptional regulation of enediyne antibiotic produc-
tion prior to the present work.
Hereby we investigated the role of sgcR3 in C-1027 bio-
synthesis, and provided an initial understanding of path-
way-specific regulatory network of sgcR1, sgcR2 and sgcR3
in S. globisporus C-1027.
Results
Overexpression of sgcR3 increased the production of 
C-1027
Computer-assisted analysis of the sgcR3  gene product
(395 aa) showed a high sequence similarity (33% identi-
ties and 47% positives) within the whole length of protein
Structure of C-1027 chromophore Figure 1
Structure of C-1027 chromophore.BMC Microbiology 2009, 9:14 http://www.biomedcentral.com/1471-2180/9/14
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TylR of S. fradiae (Fig. 2B), a pathway-specific global acti-
vator of tyl cluster [20,23]. To investigate the function of
sgcR3, the expression plasmid of sgcR3 associated with its
native promoter, named pKCR3 (see Methods), was con-
structed based on the multi-copy pKC1139 [30] and then
introduced into S. globisporus C-1027 by conjugation.
Thereafter, the resultant sgcR3 overexpression strains were
fermented by incubation in liquid medium FMC-1027-1
(see Methods). The antibacterial bioassay against Bacillus
subtilis CMCC(B) 63501 (data not shown) and the HPLC
analysis indicated that the pKCR3 led to a 30–40%
increase in C-1027 production (Fig. 3c) in comparison to
that in wild type strain (Fig. 3b), whereas C-1027 produc-
tion level detected in the wild type strain with the parental
vector pKC1139 had no difference. Therefore, the result
suggested that the function of sgcR3 could be positive for
C-1027 biosynthesis in S. globisporus C-1027.
Inactivation and complementation of sgcR3
In order to ascertain the contribution of sgcR3 to the regu-
lation of C-1027 biosynthesis, a part of coding region of
sgcR3 (507 bp) was replaced with a thiostrepton resistant
gene (tsr) to create the sgcR3 disrupted strain S. globisporus
R3KO (Fig. 4A). Successful disruption of the intended tar-
Comparison of two 9-membered enediyne (C-1027 and NCS) biosynthetic gene clusters around the genes of enediyne PKS  (sgcE and ncsE) (A) and amino acid sequence alignment for SgcR3 (B) Figure 2
Comparison of two 9-membered enediyne (C-1027 and NCS) biosynthetic gene clusters around the genes of 
enediyne PKS (sgcE and ncsE) (A) and amino acid sequence alignment for SgcR3 (B). A, Open reading frames are 
indicated by arrows. Homologue genes of regulatory sgcR1, sgcR2 and sgcR3 identified by sequence analysis are shown in grey 
or black. Genes outside of the clusters are marked by broken line arrows. B, The multialignment of S. globisporus C-1027 
SgcR3, S. carzinostaticus ATCC 15944 NscR7 and S. fradiae TylR. Identical residues are highlighted in black and similar residues 
are shaded. The numbers indicate amino acid positions.BMC Microbiology 2009, 9:14 http://www.biomedcentral.com/1471-2180/9/14
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get was confirmed by PCR using primers complementary
to one end of tsr and to untouched DNA outside the dis-
ruption constructs (data not shown). Southern blot anal-
yses authenticated the site-specific disruptions of sgcR3
using left arm for crossover and deleted part of sgcR3 gene
as probes respectively (Fig. 4B, 4C). The antibacterial bio-
assay against B. subtilis (Fig. 4D, b) and HPLC analysis
(Fig. 3d) showed that disruption of sgcR3  completely
abolished C-1027 production.
To confirm that the disruption of sgcR3  was indeed
responsible for the abolition of C-1027 production, the
mutant was complemented with sgcR3 gene. Three sgcR3
expression plasmids (pKCR3, pSETR3 and pLR3) were
introduced into R3KO mutant by conjugation respec-
tively. pSETR3 and pLR3, both based on the plasmid
pSET152 [30] integrating into the ΦC31 attB site on the
chromosome, had a copy of sgcR3 controlled by its native
promoter and a strong constitutive promoter ermE*p
respectively. The resultant strains with pKCR3 (Fig. 4D, c)
and pSETR3 (Fig. 4D, d) restored the C-1027 production
and showed dose proportionality as expected. The strain
containing pLR3 in which sgcR3 was controlled by ermE*p
showed less production of C-1027 (Fig. 4D, e) compared
with the strain containing pSETR3. No production of C-
1027 was detected for the R3KO mutants transformed
with pKC1139 and pSET152 (data not shown). These
results, fully consistent with those obtained upon overex-
pression of sgcR3 gene, confirmed the positive regulatory
role of sgcR3 in C-1027 biosynthesis.
Gene expression analysis in R3KO mutant
To investigate the role of sgcR3 gene in transcriptional reg-
ulation of C-1027 biosynthetic gene cluster, the gene
expression analysis was conducted by quantitative real
time RT-PCR. The relative level of the transcripts of two
other putative regulatory genes, sgcR1 and sgcR2, and two
biochemically characterized structural genes, sgcA1 and
sgcC4, were analysed together with sgcR3. The deduced
product of sgcR1 displays 44% end-to-end identity to StrR,
a well-characterized pathway-specific transcriptional acti-
vator for streptomycin biosynthesis in S. griseus [12].
SgcR2 shares high sequence identity (>40% along the
whole length) to AraC/XylS family transcriptional regula-
tors. SgcA1 and SgcC4 were reported to catalyze the first
step in the biosynthesis of the deoxy aminosugar and the
β-amino acid moieties of C-1027 chromophore respec-
tively [31,32]. Total RNA from the wild type strain and
R3KO mutant was extracted under which condition the
wild type strain commenced C-1027 production at about
48 h growth on S5 agar. The cDNA was synthesized and
then used as template in quantitative PCR. As expected,
sgcR3  transcripts were almost undetectable in R3KO
mutant while readily detectable in wild type strain. Tran-
Determination of C-1027 production in sgcR3 overexpres- sion strain and disruption strain R3KO Figure 3
Determination of C-1027 production in sgcR3 overex-
pression strain and disruption strain R3KO. HPLC 
analysis of C-1027 chromophore standard (a), C-1027 pro-
duced by wild type strain (b), one of sgcR3 overexpression 
strains (c) and R3KO mutant (d) are shown.
Inactivation and complementation of sgcR3 Figure 4
Inactivation and complementation of sgcR3. A, The 
plasmid pOJR3KO, constructed for sgcR3 inactivation as 
described in Methods, was used for gene disruption. Pre-
dicted restriction enzyme polymorphism caused by gene 
replacement is shown. B, BamHI; Bc, BclI; E, EcoRV. B, South-
ern blot hybridization of BamHI-digested chromosomal DNA 
of wild type strain (lane 1) and R3KO mutant (lane 2). Left 
arm for crossover is used as hybridization probe. C, South-
ern blot hybridization of EcoRV and BclI-digested chromo-
somal DNA of wild type strain (lane 1 and 2) and R3KO 
mutant (lane 3 and 4). Deleted part of sgcR3 gene is used as 
hybridization probe. D, Determination of C-1027 production 
in complementation strains of sgcR3. The antibacterial activi-
ties against B. subtilis of wild type strain (a), R3KO mutant (b), 
R3KO mutant with pKCR3 (c), R3KO mutant with pSETR3 
(d) and R3KO mutant with pLR3 (e) are shown.BMC Microbiology 2009, 9:14 http://www.biomedcentral.com/1471-2180/9/14
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scripts of the other four genes described above were also
readily detected in wild type strain, but were significant
lower in the R3KO mutant (13–22% to their counterparts
in wild type strain) (Fig. 5). The results indicated that at
the onset of the production of C-1027, sgcR3 directly or
indirectly controlled the expression of not only the struc-
tural genes that responsible for the biosynthesis of C-1027
chromophore but also the other two putative regulators
situated in the same gene cluster.
In trans complementation of R3KO mutant with sgcR1R2
The sgcR1 and sgcR2 were two adjacent genes transcribed
in the same direction with a gap of only 25 bp, suggesting
that they were transcriptionally coupled within an
operon. Confirmation that sgcR1 and sgcR2 were control-
led by sgcR3  came from in trans complementation of
R3KO mutant with sgcR1R2 (sgcR1 and sgcR2 genes). The
amplified DNA fragment of sgcR1R2 associated with its
native promoter was cloned into multi-copy pKC1139
directly or under control of ermE*p to give pKCR1R2 and
pKCER1R2. These two plasmids were introduced into
sgcR3 mutant after conjugal transfer from Escherichia coli.
C-1027 production was partially restored when sgcR1R2
was overexpressed under the control of either the native
promoter (Fig. 6c) or ermE*p (Fig. 6d). C-1027 produc-
tion was not detected in the R3KO mutants in which
pKC1139 and pSET152 were introduced (Fig. 6e, 6f). The
expression of sgcR1R2  functionally complemented the
disruption of sgcR3, together with results of the gene
expression analysis, verified that sgcR3  occupied the higher  level  than  sgcR1R2 did in the regulatory cascade for
C-1027 biosynthesis in S. globisporus C-1027.
Binding of SgcR3 to the sgcR1R2 promoter region
For further investigation of the function of sgcR3, its prod-
uct was therefore expressed as an N-terminal His10 fusion
protein in E. coli (see Methods). Subsequent SDS-PAGE
analysis revealed overproduction of a clone-specific pro-
tein of the expected size of His10-SgcR3 (45 kDa). This
His10-tagged SgcR3 protein was purified from the soluble
fraction of cell lysate by nickel affinity chromatography
and was estimated by SDS-PAGE to be about 90% pure
(Fig. 7A, lane 9).
To be a transcriptional activator of C-1027 biosynthesis,
SgcR3 was speculated that it may act as a positive regulator
by binding at or near the promoter region of biosynthetic
genes or regulatory genes and thereby activating their
transcription. EMSA were carried out to verify whether
SgcR3 indeed had DNA-binding activity, using the puri-
fied His10-tagged SgcR3 and selected DNA fragments from
the biosynthetic gene cluster of C-1027. Eight intergenic
regions of interest are chosen for EMSA, including
upstream region of sgcA1, sgcB1, sgcC1, sgcD2, sgcK, cagA,
sgcR3 and sgcR1R2 (Fig. 7B). The results showed that the
recombinant SgcR3 protein had binding activity to the
Transcriptional analyses of different genes in S. globisporus C- 1027 and R3KO mutant Figure 5
Transcriptional analyses of different genes in S. glo-
bisporus C-1027 and R3KO mutant. The relative abun-
dance of sgcR1, sgcR2, sgcA1, sgcC4 and sgcR3 transcripts in 
mycelial patches of wild type strain and R3KO mutant grown 
on S5 agar plates for 48 h was determined using quantitative 
real time RT-PCR analysis. Data are from 2 biological sam-
ples with 2 determinations each. The values were normalized 
using values obtained for hrdB mRNA and represented as the 
mean ± SD. The amounts of each particular transcript in wild 
type strain were expressed as 1.
Determination of C-1027 production in R3KO mutant com- plemented with sgcR1R2 Figure 6
Determination of C-1027 production in R3KO 
mutant complemented with sgcR1R2. The antibacterial 
activities against B. subtilis of wild type strain (a), R3KO 
mutant (b), R3KO mutant with pKCR1R2 (c), R3KO mutant 
with pKCER1R2 (d), R3KO mutant with pKC1139 (e) and 
R3KO mutant with pSET152 (f) are shown.BMC Microbiology 2009, 9:14 http://www.biomedcentral.com/1471-2180/9/14
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455 bp upstream fragment of the sgcR1R2, but not for any
other of the eight DNA fragments investigated. Further
EMSA carried out using different concentration of purified
recombinant SgcR3 showed that the shift band emerged
along with the increase of the protein amount. Shifting of
the labelled probe was not observed when the corre-
sponding unlabelled probes were added in excess to bind-
ing reaction (Fig. 7C). Specific binding of SgcR3 to the
upstream fragment of the sgcR1R2 in vitro, together with
the results of gene expression analysis and sgcR1R2 cross-
complementation in R3KO mutant, indicated that SgcR3
activates the transcription sgcR1R2 directly by binding to
its promoter region.
Discussion
The original sequence analysis of the C-1027 biosynthetic
gene cluster identified several ORFs whose gene products
may have a potential regulatory function [25]. We focused
our initial study on the sgcR3 gene situated at the right end
of the cluster. Overexpression studies with additional cop-
ies of sgcR3 expressed under the control of its native pro-
moter in wild type strain indicated a positive effect on C-
1027 production. The results obtained in the gene disrup-
tion experiment clearly demonstrated the essential posi-
tive role of sgcR3 in regulation of C-1027 biosynthesis.
The results obtained in sgcR3  inactivation experiments
were proved by complementation of the R3KO mutant
using different strategies to express sgcR3 in trans. The
results showed that expression of sgcR3 under the control
of its native promoter either introduced by a multi-copy
plasmid or integrated into the ΦC31 attB site on the chro-
mosome fully restored C-1027 production. Unexpectedly,
the complementation of sgcR3 under strong constitutive
promoter ermE*p produced less C-1027 than under its
native promoter, suggesting that the promoter region of
sgcR3  was intricately regulated for its timing or the
amount of expression which was important for the C-
1027 production. One possibility is that there is a positive
feedback mechanism controlling the expression of sgcR3,
e.g., SgcR1 and/or SgcR2 can activate the expression of
sgcR3 in return.
Analysis of gene expression in the mutant and wild type
strain suggested that sgcR3  control C-1027 production
through transcriptional regulation of biosynthetic genes.
It also helped to establish a hierarchy among the three reg-
ulators of the C-1027 gene cluster. The expression level of
sgcR1 and sgcR2 was significantly lower in R3KO mutant
than in wild type strain, implying that sgcR3 occupied a
higher rung than sgcR1 and sgcR2 did in the hierarchy of
C-1027 regulatory genes. Only TylR among SgcR3 ortho-
logues was characterized by gene disruption, in vivo com-
plementation and gene expression experiments [14,23].
Overexpression of TylR was experimentally proved to
increase tylosin yield by 60–70% [23]. According to these
studies, TylR occupies the lowest level in the genetic hier-
archy that controls tylosin production in S. fradiae, but
that was probably not the case of SgcR3 for C-1027 pro-
duction in S. globisporus C-1027.
Additional evidence for a correlation between these regu-
lators of biosynthesis was observed through the study of
cross-complementation experiment. The sgcR1R2  func-
tionally complemented R3KO mutant under either its
native promoter or strong constitutive promoter ermE*p.
Furthermore, the recombinant SgcR3 protein bound spe-
cifically to the promoter region of sgcR1R2, but not that of
sgcR3  and some structural genes detected. Therefore, it
Gel mobility-shift assays of His10-SgcR3 with sgcR1R2 pro- moter region Figure 7
Gel mobility-shift assays of His10-SgcR3 with sgcR1R2 
promoter region. A, Purification of recombinant SgcR3 
after overexpression as a fusion protein with an N-terminal 
His10-tag in E. coli BL21(DE3). Lanes 1, 2, 3 and 4 contain 
samples of the insoluble lysate of induced cells, the soluble 
lysate of induced cells, flow through from the column, com-
bined column washes respectively. Lanes 5–9 contain sam-
ples of eluates 1–5 eluted by buffer containing 500 mM 
imidazole. His10-SgcR3 protein from the eluate 5 was used in 
EMSA analysis. The molecular masses (kDa) of the protein 
markers (TransGen Biotech, Beijing, CN) are indicated. B, 
EMSA analysis of His10-SgcR3 with upstream region of sgcA1, 
sgcB1, sgcC1, sgcD2, sgcK, cagA, sgcR3 and sgcR1R2. Each of 
the lanes contains 20 fmol of fluorescently labeled promoter 
region DNA fragment. Lanes 2 also contain 13.5 pmol of 
purified recombinant His10-SgcR3 protein. C, EMSA analysis 
of His10-SgcR3 with sgcR1R2 promoter region. Each of the 
lanes contains 20 fmol of fluorescently labeled sgcR1R2 pro-
moter region DNA fragment. Lanes 2–6 also contain 0.5 
pmol, 3.12 pmol, 6.25 pmol, 13.5 pmol and 27 pmol of puri-
fied recombinant His10-SgcR3 protein, respectively. Lane 7 
contains 6.25 pmol His10-SgcR3 and 200 fold excess unla-
beled sgcR1R2 promoter region DNA fragment.BMC Microbiology 2009, 9:14 http://www.biomedcentral.com/1471-2180/9/14
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was very likely that SgcR3 activated the transcription of
sgcR1  and  sgcR2  by directly binding to their promoter
region, to control the expression of biosynthetic structural
genes indirectly. On the other hand, although the recom-
binant SgcR3 can bind to sgcR1R2 promoter region DNA
fragment without further macromolecular factor in vitro,
our results do not completely rule out the possibility that
other protein(s) may be required for activating the tran-
scription of sgcR1R2.
With few except that no regulatory gene present in the bio-
synthetic gene cluster, e.g., erythromycin cluster of Saccha-
ropolyspora erythraea [33], most much-studied antibiotic
gene clusters contain at least one pathway-specific regula-
tor. However, the biosynthesis of more complex mole-
cules may need more regulatory gene products involving
a regulatory cascade to affect a positive or negative regula-
tion. Some particularly interesting examples are the
tylosin biosynthetic gene cluster of S. fradiae
[14,18,19,21-23] and the rapamycin biosynthetic gene
cluster of S. hygroscopicus [16] which contain, remarkably,
no fewer than five putative regulatory genes. Further anal-
ysis of other ORFs in C-1027 gene cluster revealed that
additional three unknown genes might have regulatory
role in C-1027 biosynthesis. The sgcE1 encodes a protein
homologous (43% end-to-end identity) to a transcrip-
tional regulator of HxlR family (GenBank accession no.
ABX37987). The sgcR encodes a protein demonstrating
some homology (20% end-to-end identity) to a transcrip-
tional regulator protein (GenBank accession no.
EDS60418) which belongs to XRE (Xenobiotic Response
Element) family. The deduced product of sgcM was also
found to be highly similar to a putative DNA-binding pro-
tein of S. coelicolor A3(2) with a helix-turn-helix motif
(GenBank accession no. NP_630506.1). Both sgcE1 and
sgcM have a highly homologous counterpart in NCS bio-
synthetic gene cluster of S. carzinostaticus. This is not sur-
prising due to the complicated biosynthesis of enediyne
chromophore, which involves multiple moieties and a
convergent biosynthetic approach used to piece together
the final product.
This work is the first step in deciphering the regulatory fac-
tors involved in the biosynthesis of C-1027, and a primary
model for pathway-specific regulation of C-1027 produc-
tion is shown in Fig. 8. Therefore, precise roles for sgcR3,
sgcR1, sgcR2 and other putative regulatory genes and their
complex interaction remain to be defined. The data pre-
sented in this work set the stage for subsequent studies to
delineate the complexity of the regulation of C-1027 bio-
synthesis, as well as for designing strategies for the con-
struction of strains with enhanced C-1027 production.
Conclusion
The available evidence demonstrated that SgcR3 was a
transcriptional activator in C-1027 biosynthesis. Also,
sgcR3  was demonstrated to occupy a higher level than
sgcR1 and sgcR2 does in the regulatory cascade of C-1027
biosynthesis in S. globisporus C-1027 and activate the tran-
scription of sgcR1R2 by directly binding to its promoter
region.
Methods
Strains, media and growth conditions
E. coli DH5α was used as host for cloning experiments. E.
coli  ET12567/pUZ8002 [34] was used to transfer DNA
into  S. globisporus by conjugation. E. coli BL21 (DE3)
(Novagen, Madison, USA) was used to express SgcR3 pro-
tein. They were grown either on solid or in liquid Luria-
Bertani medium (LB) at 37°C. The following antibiotics
were used to select recombinant E. coli strains: 100 μg
ampicillin (Ap) ml-1, 50 μg kanamycin (Km) ml-1, 25 μg
chloramphenicol (Cm) ml-1 or 50 μg apramycin (Am) ml-
1. B. subtilis CMCC(B) 63501 was used as the test organ-
ism for assay of the antibacterial activity of C-1027 [35],
grown on solid F403 agar (consisting of 0.5% peptone,
0.3% beef extract, 0.3% K2HPO4 and 1.5% agar (pH 7.8))
at 37°C.
S. globisporus C-1027 (referred to here as wild type strain)
and its derivatives were grown at 28°C on S5 agar (con-
sisting of 0.1% KNO3, 0.05% NaCl, 0.05% K2HPO4,
0.001% FeSO4, 0.05% MgSO4, 2.0% starch and 1.5% agar
(pH 7.2)) for sporulation, on mannitol soya flour (MS)
agar [34] for conjugation, in the liquid fermentation
medium FMC-1027-1 (consisting of 2% dextrin, 0.2%
peptone, 1% glycerol, 0.5% corn steep liquor and 0.1%
Hypothetical schematic regulatory hierarchy of C-1027 bio- synthesis in S. globisporus C-1027 Figure 8
Hypothetical schematic regulatory hierarchy of C-
1027 biosynthesis in S. globisporus C-1027. Break line 
box with interrogation point represents unknown pathway-
specific regulatory genes and break line arrow represents 
hypothetic feedback regulation. (+) indicates positive regula-
tion and (?) indicates unknown possible regulation.BMC Microbiology 2009, 9:14 http://www.biomedcentral.com/1471-2180/9/14
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CaCO3 (pH 7.0)) for C-1027 production, in Trypticase
Soy Broth (TSB, BD, Sparks, USA) for isolation of genomic
or plasmid DNA, and maintained as mycelial fragments
or spores in 20% (v/v) glycerol at -70°C. The antibiotics
apramycin (Am) and thiostrepton (Th) were added at
final concentrations of 50 and 30 μg ml-1  to solid
medium, and at 10 and 5 μg ml-1 to liquid medium,
respectively. Strains used and constructed in this study are
listed in Table 1.
DNA manipulations
Standard genetic techniques with E. coli and in vitro DNA
manipulations were as described by Sambrook & Russell
[36]. Plasmids used and constructed in this study are
listed in Table 1. Recombinant DNA techniques in Strep-
tomyces species were performed as described by Kieser et
al. [34]. PCR reactions for amplification of indicated DNA
products and for verification of gene deletion in S. globis-
porus were carried out using Pfu DNA polymerase (Trans-
Gen Biotech, Beijing, CN). The primers for PCR
amplification are shown in Table 2. Total S. globisporus
DNA was isolated using the Kirby mix procedure [34].
Southern blot analysis was performed on Hybond-N+
nylon membrane (Amersham Biosciences, Buckingham-
shire, UK) with a fluorescein-labelled probe by using the
Gene Images Random Prime Labelling Module and CDP-
Star Detection Kit (Amersham Biosciences).
Construction of expression plasmids
Three plasmids for sgcR3 expression were constructed as
follows. The sgcR3 with its promoter region (2,539 bp)
was amplified by PCR and then cloned into the E. coli/
Streptomyces shuttle vector pKC1139 [30] to give pKCR3.
The fragment was also ligated into an integrative vector
pSET152 [30] to give pSETR3. The sgcR3 coding region
(1,188 bp) amplified by PCR was introduced to pL646
[37], displacing atrAc gene under the control of a strong
constitutive promoter ermE*p, to give pLR3.
Similarly, sgcR1R2 (2,461 bp) with its promoter region
were amplified by PCR and cloned into pKC1139 vector
to yield pKCR1R2. This fragment was also cloned into
pKC1139 under the control of ermE*p, resulting in plas-
mid pKCER1R2.
Disruption of sgcR3
The disruption construct consists of a thiostrepton resist-
ant gene (tsr), sandwiched between two PCR products
("arms") that each contains sequence from sgcR3  plus
flanking DNA. The arms (which were authenticated by
sequence analysis) were of approximately equal size (1.4
kbp).
The primers for sgcR3 disruption introduced restriction
sites into the arms (EcoRI and BglII in the upstream arm,
BglII and HindIII in the downstream arm), and thus
Table 1: Bacterial strains and plasmids used in this study
Strains or plasmids Description* Reference
Strains
Escherichia coli DH5α General cloning host [36]
E. coli ET12567/pUZ8002 Strain used for E. coli/Streptomyces conjugation [34]
E. coli BL21 (DE3) Strain used for the expression of SgcR3 protein Novagen
Bacillus subtilis CMCC(B) 63501 Strain used for C-1027 bioassays [35]
Streptomyces globisporus C-1027 Wild type C-1027 producing strain [1]
S. globisporus R3KO S. globisporus C-1027 with disruption of sgcR3, Thr This work
Plasmids
pUC18 General cloning vector, Apr [36]
pET-16b E. coli expression vector, Apr Novagen
pKC1139 E. coli/Streptomyces shuttle vector, Amr [30]
pOJ260 Suicide vector nonreplicating in Streptomyces, Amr [30]
pSET152 Streptomyces integrative vector, Amr [30]
pL646 pSET152 derivative plasmid containing ermE*p and the ribosome-binding site of the tuf1 gene 
upstream atrAc gene, Amr
[37]
pOJR3KO pOJ260 derivative plasmid with the disruption of sgcR3, Thr This work
pKCR3 pKC1139 derivative plasmid containing 2,539 bp fragment of sgcR3 including its native promoter, 
Amr
This work
pSETR3 pSET152 derivative plasmid containing 2,539 bp fragment of sgcR3 including its native promoter, 
Amr
This work
pLR3 pL646 derivative plasmid containing 1,188 bp coding region of sgcR3 instead of atrAc, Amr This work
pKCR1R2 pKC1139 derivative plasmid containing 2,461 bp fragment of sgcR1R2 including its native promoter, 
Amr
This work
pKCER1R2 pKC1139 derivative plasmid containing 2,461 bp fragment of sgcR1R2 under the ermE*p, Amr This work
*Abbreviations: Apr, ampicillin resistance; Amr, apramycin resistance; Thr, thiostrepton resistance.BMC Microbiology 2009, 9:14 http://www.biomedcentral.com/1471-2180/9/14
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Table 2: PCR primers used in this study
Name Sequence Purpose
WAB1
WAB2
5'-GAGAATTCACCACATGGAACATCTGCTG-3'
5'-GAAGATCTGGGAGCACGCAACTGAG-3'
Forward and reverse primers for amplifying 1.4 kbp upstream arm used 
in knockout of sgcR3
WCD1
WCD2
5'-AAGATCTCTGATCGGCAAGTACGGAGAC-3'
5'-AAAGCTTGGTGACAGTTCCGAGGAGGTT-3'
Forward and reverse primers for amplifying 1.4 kbp downstream arm 
used in knockout of sgcR3
H1
H2
5'-CAGAATTCTCTCCTACGCCCTGCTCATC-3'
5'-ACTCTAGAAGAACCGCTCGGCCTGTC-3'
Forward and reverse primers for amplifying 2,539 bp sgcR3 including its 
native promoter
sgcR3_FOR
sgcR3_REV
5'-GCATATGGCGGCACACGACGTGAG-3'
5'-AGGATCCCAGCTCCCCTCCTGGGAG-3'
Forward and reverse primers for amplifying 1,188 bp sgcR3 coding 
region
P17
P18
5'-ATGGATCCGCCCCTCGCTCATTGTCG-3'
5'-ATGAATTC CGGATCGGATGTGCTGGTCT-3'
Forward and reverse primers for amplifying 2,461 bp sgcR1R2 including 
its native promoter
hrdBRT1
hrdBRT2
5'-TGGTCGAGGTCATCAACAAG-3'
5'-TGGACCTCGATGACCTTCTC-3'
Forward and reverse primers used for the detection of hrdB transcripts
R1RT1
R1RT2
5'-GAAAAGTGACTCTGCCCAACGC-3'
5'-CGCTGCACATGGGAACGATC-3'
Forward and reverse primers used for the detection of sgcR1 transcripts
R2RT1
R2RT2
5'-ACCACGAACACCATCGAGGAC-3'
5'-CGGAAGATGCGGGTGAAATG-3'
Forward and reverse primers used for the detection of sgcR2 transcripts
R3RT1
R3RT2
5'-GTGGGCGAACGGGAGACGGT-3'
5'-TGCCGAGGGCCGATCAGAGG-3'
Forward and reverse primers used for the detection of sgcR3 transcripts
A1RT1
A1RT2
5'-CAGAACATATTCAAGGACTGGC-3'
5'-CACTTGTACTGTCGGGTGGTT-3'
Forward and reverse primers used for the detection of sgcA1 transcripts
C4RT1
C4RT2
5'-CTGTGGCTACGGACGAGATTG-3'
5'-CCGAACAGAACATCCCCATCT-3'
Forward and reverse primers used for the detection of sgcC4 transcripts
sgcA1p_FOR_F
sgcA1p_REV
5'-CAGCTGGAGTACGCGATGG-3'
5'-CGACAATGGCGACCTC TTTG-3'
Forward and reverse primers for amplifying 438 bp upstream of sgcA1
sgcB1p_FOR_F
sgcB1p_REV
5'-GAGGGGTTTTGAGGGGTGAA-3'
5'-GATAGGGGTCGGGGGACATC-3'
Forward and reverse primers for amplifying 496 bp upstream of sgcB1
sgcC1p_FOR_F
sgcC1p_REV
5'-GGTGCAACACCGCAGATCC-3'
5'-GAGCTGCGCGGAAGGAAG-3'
Forward and reverse primers for amplifying 481 bp upstream of sgcC1
sgcD2p_FOR_F
sgcD2p_REV
5'-CCTGGAACCATCCGCGAAAC-3'
5'-CGGTCGATCACCAGCACTTC-3'
Forward and reverse primers for amplifying 448 bp upstream of sgcD2
sgcKp_FOR_F
sgcKp_REV
5'-AGGATCATCGTCCCGTCTC-3'
5'-GAGCCAGTCGAACGACTCCA-3'
Forward and reverse primers for amplifying 471 bp upstream of sgcK
R1R2p_FOR_F
R1R2p_REV
5'-ACGATCGTGTCCGCGTAGG-3'
5'-AACGATCGATTCCGTTCAGG-3'
Forward and reverse primers for amplifying 455 bp upstream of sgcR1R2
R3p_FOR_F
R3p_REV
5'-GCCCACGCCCTCTGATCG-3'
5'-CGGGACCATGCTCCGTGTA-3'
Forward and reverse primers for amplifying 467 bp upstream of sgcR3
cagApEMSA1
cagApEMSA2
5'-CACGCTCTGTCCGTCACTCA-3'
5'-ATCCGCTCCCGAAGGTGG-3'
Forward and reverse primers for amplifying 429 bp upstream of cagA
Restriction endonuclease recognition sequences introduced by these oligonucleotides are bold.BMC Microbiology 2009, 9:14 http://www.biomedcentral.com/1471-2180/9/14
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allowed fusion at the BglII sites by ligation into pUC18.
Then, the tsr fragment (a 1 kbp BclI restriction fragment
from pIJ680 [34]) was introduced into the BglII site and
thereby displaced 507 bp of sgcR3. Disrupted sgcR3 plus
flanking DNA (approximate 3.8 kbp in total) was ligated
into suicide plasmid pOJ260 [30] to give pOJR3KO. This
plasmid was introduced by transformation into E. coli
ET12567/pUZ8002 and then transferred into S. globisporus
C-1027 by conjugation. Double-crossover exconjugants
were selected on MS agar containing Th and Am (Thr,
Ams). Deletions within sgcR3 were confirmed by PCR and
Southern blot hybridization.
Gene expression analysis by real time reverse transcriptase 
PCR (RT-PCR)
RNA was isolated from S. globisporus mycelia scraped from
cellophane laid on the surface of S5 agar plates, treated
with DNaseI (Promega, WI, USA) and quantitated as
described previously [37,38]. The first strand synthesis of
cDNA was performed with SuperScript III First-strand
Synthesis System (Inivitrogen, CA, USA) using 2 μg total
RNA and the random hexamers as primers following the
manufacturer's instructions. Oligonucleotides were
designed to amplify fragments of about 100–150 bp from
the target genes (Table 2).
Quantitative real time PCR of selected genes was per-
formed using the SYBR Green PCR Master Mix (ABI,
Cheshire, UK). To control for genomic DNA contamina-
tion, each sample was also incubated with a reaction mix-
ture that lacked RT. Real time PCR conditions were as
follows: 94°C for 10 min, 40 cycles of 94°C for 30 s, 60°C
for 30 s and 72°C for 30 s. A step of 78°C for 10 s during
which fluorescence was measured was included at the end
of each cycle. The reactions were subjected to a heat disso-
ciation protocol after the final cycle of PCR to indicate the
proper temperature for fluorescence detection. After PCR
amplifications, data were analyzed with iQ5 Optical Sys-
tem version 1.1.1442.0 Software (Bio-Rad). The threshold
cycle (Ct) was calculated from the programme. Serial dilu-
tion of the cDNA was subjected to real time PCR. For each
transcript, plots of Log2(dilution factor) against the Ct val-
ues provided an estimate of the efficiency of the amplifi-
cation. The target gene mRNA level were normalised
internally to the level of hrdB  mRNA according to the
Pfaffl's method [39].
C-1027 production and analysis
For C-1027 production, S. globisporus strains were grown
in liquid medium FMC-1027-1 by a two-stage fermenta-
tion. The spore suspensions of the different strains were
adjusted to the same concentration for inoculation. The
seed inoculum was prepared by inoculating 100 ml of
FMC-1027-1 with an aliquot of the spore suspension and
incubating the mixture at 28°C and 250 rpm for 2 days.
The seed culture (5%) was added to a fresh 100 ml of
FMC-1027-1, continuing to incubate at 28°C and 250
rpm for 5 days. To obtain statistically significant results,
each strain was represented by a triplicate sample set. Dry
weight of mycelia was measured in cultures taken at differ-
ent time points in the fermentation course and the pattern
of growth curves were monitored consistently among the
relevant strains. The production of C-1027 was analyzed
using the fermentation supernatants of relevant strains
with the same growth curves.
C-1027 production was detected by assaying its antibacte-
rial activity against B. subtilis [35]. The fermentation super-
natant (180 μl) was added to stainless steel cylinders
placed on F403 agar plate containing B. subtilis spores
(0.4% v/v). C-1027 production was estimated by measur-
ing the sizes of the inhibition zones after incubated at
37°C for 12 h.
Isolation and high-pressure liquid chromatography
(HPLC) analysis of C-1027 chromophore were carried out
mostly following Liu et al. [25]. Briefly, (NH4)2SO4 was
added to the 250 ml fermentation supernatant of relevant
strains to 100% saturation and then adjusted to pH 4.0
with 0.1 M HCl. The precipitated C-1027 chromoprotein
was dissolved in 15 ml 0.1 M potassium phosphate (pH
8.0). The supernatant was then extracted with 50 ml ethyl
acetate (EtOAc), concentrated in vacuum, and re-dis-
solved in 250 μl methanol. 25 μl cleared sample was sub-
jected to HPLC on a Kromasil C-18 column (5 μm, 150 ×
4.6 mm, Bohus, SE), eluted isocratically with 20 mM
potassium phosphate (pH 6.86)/CH3CN (50:50, v/v) at a
flow rate of 1.0 ml/min and detected by monitoring UV
absorbance at 350 nm. The C-1027 enediyne chromo-
phore standard for HPLC analysis was confirmed by ESI-
MS.
Expression and purification of His10-tagged SgcR3
The sgcR3 coding sequence was PCR-amplified from S. glo-
bisporus  C-1027 genome DNA containing an NdeI and
BamHI restriction sites, and then ligated into pET-16b
(Novagen, Madison, USA), authenticated by sequencing,
and then transformed into the E. coli BL21 (DE3). For pro-
duction of His10-tagged SgcR3, cultures (800 ml; OD600 =
0.6) were induced with IPTG (0.05 mM final), incubated
at 28°C for 6 h, harvested by centrifugation. The cell sus-
pension was sonicated for 60 × 10 s with 10 s intervals
between each treatment in 30 ml lysis buffer (50 mM
NaH2PO4, pH 8.0, 300 mM NaCl, 10 mM imidazole, 2
mg lysozyme ml-1). Cellular debris was removed by cen-
trifugation (12,000 rpm for 10 min). His10-tagged SgcR3
was then affinity purified using HisTrap™ FF crude (Amer-
sham Biosciences) according to the manufacturer's direc-
tions and fractions eluted from the column were analysed
on SDS-12% w/v polyacrylamide gels. Those fractionsBMC Microbiology 2009, 9:14 http://www.biomedcentral.com/1471-2180/9/14
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containing recombinant protein were pooled, dialysed
overnight at 4°C against dialysis buffer (25 mM Tris/HCl
(pH 7.5), 10% (w/v) glycerol, 2 mM DTT) and stored at -
70°C. The BCA™ Protein Assay Kit (Pierce Biotechnology,
Rockfold, USA) was used for protein quantification with
bovine serum albumin as the standard.
Electrophoretic mobility shift analysis (EMSA)
DNA fragments upstream of sgcR1R2, sgcR3, sgcA1, sgcB1,
sgcC1, sgcD2, sgcK and cagA were generated by PCR using
S. globisporus C-1027 genomic DNA as template. Primers
are shown in Table 2. After purification by agarose electro-
phoresis, these DNA fragments were 3'-end labelled with
Biotin-11-ddUTP using the Biotin 3' End DNA Labeling
Kit (Pierce Biotechnology). Probes were incubated at 4°C
for 20 min with purified His10-SgcR3 protein in binding
buffer (100 mM Tris/HCl (pH 7.5), 500 mM KCl, 10 mM
DTT). Reaction mixtures were then analysed by non-dena-
turing PAGE (5% w/v gels) in 0.5 × TBE buffer at 4°C. The
gel was then transferred to nylon membrane (Amersham
Biosciences) by electrophoretic transfer. The biotin end-
labeled DNA was detected by LightShift Chemilumines-
cent EMSA Kit (Pierce Biotechnology) according to the
manufacturer's instructions.
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